Literature DB >> 7969947

Overview of diagnosis and treatment of migraine.

S D Silberstein1, R B Lipton.   

Abstract

Optimal migraine therapy begins with an accurate diagnosis and knowledge of the symptoms that the patient finds most disturbing. Pharmacologic treatment of migraine may be acute (abortive, symptomatic) or preventive (prophylactic); both approaches are frequently required in patients with frequent, severe headaches. Drugs for acute care consist of analgesics, antiemetics, anxiolytics, nonsteroidal anti-inflammatory drugs, ergots, steroids, major tranquilizers, narcotics, and selective serotonin agonists. Preventive agents include beta-blockers, calcium channel blockers, antidepressants, serotonin antagonists, and anticonvulsants. The choice of a preventive drug depends on side effect profiles and comorbid conditions. Behavioral interventions, such as biofeedback and relaxation techniques, are an important complement to pharmacologic therapy; however, drugs are the mainstay of migraine therapy. To ensure that therapy achieves optimal results, the individual patient's preferred approach to this debilitating problem must be considered carefully.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969947

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

Review 1.  Almotriptan: a review of its use in migraine.

Authors:  Susan J Keam; Karen L Goa; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Natural history of headache after traumatic brain injury.

Authors:  Jeanne M Hoffman; Sylvia Lucas; Sureyya Dikmen; Cynthia A Braden; Allen W Brown; Robert Brunner; Ramon Diaz-Arrastia; William C Walker; Thomas K Watanabe; Kathleen R Bell
Journal:  J Neurotrauma       Date:  2011-08-29       Impact factor: 5.269

3.  Medication overuse headache following repeated morphine, but not [INCREMENT]9-tetrahydrocannabinol administration in the female rat.

Authors:  Ram Kandasamy; Cole T Dawson; Tammy N Hilgendorf; Michael M Morgan
Journal:  Behav Pharmacol       Date:  2018-08       Impact factor: 2.293

4.  Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats.

Authors:  D J Williamson; S L Shepheard; D A Cook; R J Hargreaves; R G Hill; M J Cumberbatch
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

5.  Migraine in women with chronic pelvic pain with and without endometriosis.

Authors:  Barbara Illowsky Karp; Ninet Sinaii; Lynnette K Nieman; Stephen D Silberstein; Pamela Stratton
Journal:  Fertil Steril       Date:  2010-12-10       Impact factor: 7.329

Review 6.  Practical approaches to migraine management.

Authors:  Seymour Diamond; Richard Wenzel
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

7.  Mental turmoil, suicide risk, illness perception, and temperament, and their impact on quality of life in chronic daily headache.

Authors:  Sergio De Filippis; Denise Erbuto; Federica Gentili; Marco Innamorati; David Lester; Roberto Tatarelli; Paolo Martelletti; Maurizio Pompili
Journal:  J Headache Pain       Date:  2008-10-25       Impact factor: 7.277

8.  The validation of the Italian Perceived Disability Scale (IPDS) in chronic daily headache sufferers.

Authors:  Marco Innamorati; Maurizio Pompili; Sergio De Filippis; Federica Gentili; Denise Erbuto; David Lester; Antonino Tamburello; Giulia Iacorossi; Ilaria Cuomo; Giovanni Dominici; Roberto Tatarelli; Paolo Martelletti
Journal:  J Headache Pain       Date:  2008-10-15       Impact factor: 7.277

9.  The human μ-opioid receptor gene polymorphism (A118G) is associated with head pain severity in a clinical cohort of female migraine with aura patients.

Authors:  S Menon; R A Lea; B Roy; M Hanna; S Wee; L M Haupt; L R Griffiths
Journal:  J Headache Pain       Date:  2012-06-30       Impact factor: 7.277

10.  Headache in pregnancy: a nuisance or a new sense?

Authors:  Archana Dixit; Manish Bhardwaj; Bhavna Sharma
Journal:  Obstet Gynecol Int       Date:  2012-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.